Investigational Drug Information for Lysergic acid diethylamide
What is the drug development status for Lysergic acid diethylamide?
Lysergic acid diethylamide is an investigational drug.
There have been 20 clinical trials for Lysergic acid diethylamide.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2019.
The most common disease conditions in clinical trials are Headache, Cluster Headache, and Anxiety Disorders. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Eleusis Therapeutics, and University of Fribourg.
There are zero US patents protecting this investigational drug and zero international patents.
Summary for Lysergic acid diethylamide
| US Patents | 2,069 |
| International Patents | 6,556 |
| US Patent Applications | 3,928 |
| WIPO Patent Applications | 1,944 |
| Japanese Patent Applications | 440 |
| Clinical Trial Progress | Phase 2 (2019-11-01) |
| Vendors | 9 |
Recent Clinical Trials for Lysergic acid diethylamide
| Title | Sponsor | Phase |
|---|---|---|
| LSD Occupancy of the Serotonin 2A Receptor in the Human Brain | Rigshospitalet, Denmark | Early Phase 1 |
| Lysergic Acid Diethylamide (LSD) in Palliative Care | University Hospital, Zürich | Phase 2 |
| Lysergic Acid Diethylamide (LSD) in Palliative Care | University Hospital, Basel, Switzerland | Phase 2 |
Clinical Trial Summary for Lysergic acid diethylamide
Top disease conditions for Lysergic acid diethylamide
Top clinical trial sponsors for Lysergic acid diethylamide
US Patents for Lysergic acid diethylamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Lysergic acid diethylamide | ⤷ Start Trial | High-stretch energy curable inks and method of use in heat transfer label applications | Sun Chemical Corp | ⤷ Start Trial |
| Lysergic acid diethylamide | ⤷ Start Trial | Wearable apparatus for detecting a target substance in a liquid | Undercover Colors, Inc. (Raleigh, NC) | ⤷ Start Trial |
| Lysergic acid diethylamide | ⤷ Start Trial | Methods for treatment or prevention of damage resulting from radiation, trauma or shock | Synedgen Inc | ⤷ Start Trial |
| Lysergic acid diethylamide | ⤷ Start Trial | Particles with quantum dots and method of making the same | 3M Innovative Properties Co | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Lysergic acid diethylamide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Lysergic acid diethylamide | Argentina | AR107479 | 2036-01-27 | ⤷ Start Trial |
| Lysergic acid diethylamide | Argentina | AR107480 | 2036-01-27 | ⤷ Start Trial |
| Lysergic acid diethylamide | Argentina | AR107481 | 2036-01-27 | ⤷ Start Trial |
| Lysergic acid diethylamide | Australia | AU2017211860 | 2036-01-27 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
